Stocks and Investing
Stocks and Investing
Wed, March 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ed Arce Maintained (TERN) at Hold with Increased Target to $11 on, Mar 29th, 2023
Ed Arce of HC Wainwright & Co., Maintained "Terns Pharmaceuticals, Inc." (TERN) at Hold with Increased Target from $7 to $11 on, Mar 29th, 2023.
Ed has made no other calls on TERN in the last 4 months.
There are 2 other peers that have a rating on TERN. Out of the 2 peers that are also analyzing TERN, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $19 on, Tuesday, February 7th, 2023
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $14 on, Tuesday, December 20th, 2022
Contributing Sources